Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
États-Unis (2)
Advocacy (policy advocacy, lobbying)
Musculoskeletal/Multiple Sclerosis (MS) (1)
Pharmaceutical Company (9)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Transparency in communication and documentation
Clinical study phase I